62.84% | % of shares held by all insiders |
18.55% | % of shares held by institutions |
49.92% | % of float held by institutions |
478 | Number of institutions holding shares |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
Baillie Gifford and Company | 8,358,939 | 31 Mar 2024 | 3.52% | 1,391,512,585 |
Primecap Management Company | 4,807,918 | 31 Mar 2024 | 2.02% | 800,374,115 |
Harding Loevner LLC | 3,818,163 | 31 Mar 2024 | 1.61% | 635,609,599 |
Flossbach von Storch AG | 3,468,986 | 31 Mar 2024 | 1.46% | 577,482,103 |
Temasek Holdings (Private) Limited | 3,430,250 | 31 Mar 2024 | 1.44% | 571,033,721 |
Blackrock Inc. | 1,906,841 | 31 Mar 2024 | 0.80% | 317,431,823 |
Morgan Stanley | 1,083,910 | 31 Mar 2024 | 0.46% | 180,438,499 |
Capital World Investors | 943,116 | 31 Mar 2024 | 0.40% | 157,000,521 |
FMR, LLC | 834,390 | 31 Mar 2024 | 0.35% | 138,900,904 |
Quinn Opportunity Partners, LLC | 713,383 | 31 Mar 2024 | 0.30% | 118,756,868 |
Holder | Shares | Date reported | % out | Value |
---|---|---|---|---|
Vanguard Horizon Fund-Capital Opportunity Fund | 2,357,736 | 31 Dec 2023 | 0.99% | 392,492,314 |
Harding, Loevner Funds, Inc-International Equity Portfolio | 1,890,737 | 31 Jan 2024 | 0.80% | 314,750,990 |
iShares Biotechnology ETF | 1,552,394 | 31 Mar 2024 | 0.65% | 258,427,031 |
Primecap Odyssey Aggressive Growth Fund | 1,362,792 | 31 Mar 2024 | 0.57% | 226,863,985 |
New Perspective Fund Inc | 799,519 | 31 Mar 2024 | 0.34% | 133,095,928 |
Primecap Odyssey Growth Fund | 437,900 | 31 Mar 2024 | 0.18% | 72,897,213 |
First Trust NYSE Arca Biotechnology Index Fund | 426,947 | 30 Apr 2024 | 0.18% | 71,073,867 |
Fidelity Contrafund Inc | 342,586 | 31 Mar 2024 | 0.14% | 57,030,291 |
Baron Focused Growth Fund | 200,000 | 31 Dec 2023 | 0.08% | 33,294,000 |
Legg Mason Glb Asset Mgt Tr-Clearbridge Value Trust | 200,000 | 31 Jan 2024 | 0.08% | 33,294,000 |